Nevada ‘Medicaid for all’ bill vetoed

Nevada Gov. Brian Sandoval has vetoed legislation to create a Medicaid buy-in option in the state.

The legislation, sponsored by Nevada Assemblyman Michael Sprinkle, a Democrat, would have allowed Nevada residents who qualify for subsidies under the Affordable Care Act could use that money to buy in, and those who don’t receive subsidies would be able to use their own money, thus creating a new public health insurance option. 

The legislation—dubbed “SprinkleCare” after its main sponsor—passed along party lines among state legislators. Sandoval, a Republican, rejected the bill on the grounds the idea needed further study.

“Moving too soon, without factual foundation or adequate understanding of the possible consequences, could introduce more uncertainty to an already fragile healthcare market, and ultimately affect patient health care,” Sandoval wrote in his veto message.

Among the provisions in the bill which were left up to state regulators were what kind of copays and deductibles the buy-in customers would be required to pay. Despite the veto, Sprinkle said he’ll bring the bill back in Nevada’s next legislative session.

“I will continue to believe that health care is a right and not a privilege and to make sure your government provides you with that right,” Sprinkle said in a statement. “Though today's veto is highly disappointing my job as your legislator is to make sure you have access to affordable and quality health care. As an elected representative I take that responsibility very seriously and will work hard in the future to protect all people's right to health care, not just the privileged.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”